Piper Sandler Reiterates a Buy Rating on UnitedHealth Group (UNH)

UnitedHealth Group Incorporated (NYSE:UNH) is one of the best stocks to invest in for beginners. Piper Sandler analyst Jessica Tassan reiterated a Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) on August 5, setting a price target of $280.00.

UnitedHealth Group Incorporated (NYSE:UNH) reported that its Q2 2025 revenue underwent a $12.8 billion year-over-year growth to $111.6 billion, attributed primarily to growth within Optum and UnitedHealthcare.

Earnings from operations for the quarter were $5.2 billion, while adjusted net earnings were $4.08 per share.

Management reported a full year 2025 revenue outlook in the $445.5 billion to $448.0 billion range, with a full year 2025 earnings outlook of at least $14.65 per share.

UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.